Lillys approval for Mounjaro in Obesity will result in a duopoly in the space, with clinical stage biopharma (mentioned below) likely 2 years from having a drug on the market
Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Furtado RHM, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Sabatine MS
Overcoming ED When Other Drugs Fail: Because PT-141 uses a neurological pathway rather than a vascular one, it often works beautifully for men who do not respond to traditional ED medications, or it simply provides a more natural-feeling experience
Your provider sets your starting dose and a gradual step-up plan, personalized to you and documented in your patient portal